A glimpse of the #PSOGI2021 scientific program From training to basics to the recent progress in the field of peritoneal malignancies, the one meeting that covers it all. glen Santiago González-Moreno SoMe4Peritoneum ISSPP @RENAPE_Network INDEPSO Asociación Peritoneum Sociedade Brasileira de Cirurgia Oncológica (SBCO)

12th PSOGI Meeting Peritoneal Surface Oncology Group International

Watch it live now..

Opening session Pr. Jin Gu- welcome from the Chinese society of oncology Pr. Que Zhang- announcement of the Beijing peritoneal oncology group Pr. Rhonghua Kong- release of the 1st Chinese textbook on HIPEC Pr. Shuzhong Cui- about the 1st Chinese textbook on HIPEC

The global campaign on peritoneal metastases Progress and efforts by the PSOGI in the last 20 years by #PaulSugarbaker

Training is the key to success in Peritoneal Oncology Santiago González-Moreno Skills required to manage PM cannot be acquired during surg/gynec onc training From few pioneers & limited surgeons having access to training ▶️creation of European school of Perioneal surface Oncology(ESPSO)

New board members of the ESPSO include Academic coordinator and faculty Lana Bijelic Winston Liauw -systemic therapy #clarissedromain- imaging #fredericbibeau - pathology #lauralambert- palliative care

Live updates on #PSOGI2021 PSOGI 2021 Beijing AT Peritoneal Surface Oncology Group International Recordings available to those who have registered and missed the session on the conference website

Prof David Morris discussing new concepts and drugs for treating recurrent PMP and appendiceal PM Good survival for some histologies with redo surgery

Therapeutic rationale and early results of using BromAc in unresectable PMP Centres across Europe and USA will start recruiting patients for a multi-centre study very soon Alvaro Arjona Vahan Képénékian Winston Liauw

Prof. Yutaka Yonemura Laparoscopic HIPEC as neoadjuvant therapy Calculating the thermal dose and the response to neoajduvant HIPEC in #gastricPM

Reduction in PCI, survival and prognostic factors with NIPS and L-HIPEC

Back to basics #BeateRau How to calculate the PCI.. The PCI is more than just a number What other important information can be derived from it? Andreas Brandl SoMe4Peritoneum Asociación Peritoneum

ONE LANGUAGE for all tumors, in all countries- PCI

Evolution of an expert centre over 30 years that is at the forefront of treatment of PM and has trained surgeons across the world by Brendan Moran Faheez Mohamed Tom Cecil Dr Nabila Ansari Umar Shariff Nima Ahmadi Faraz Khan

Best abstract #1 Mohammad Alyami Dr.Mohammad ALYAMI Cohort study on PIPAC for gastric PM 586 pts, 1566 PIPACs -45%>3 PIPACs 4.3% CR, 11% PR, 44% stable dz Median OS 20months for >3PIPACs ISSPP glen clarisse Olivia Sgarbura Martin Hübner

Pompiliu Piso German perspective and experience -The no of patients treated is increasing -Encouraging results with HIPEC and PIPAC -OS results from the COMBATAC study to be presented at #ESMO2021

the PREVENT trial for prophylactic HIPEC in gastric cancer is recruiting patients in Germany Will evaluate the role of HIPEC in addition to surgery and FLOT chemotherapy regimen Dr.Mohammad ALYAMI clarisse Andreas Brandl Faraz Khan